Disclosure 0001780649-26-000014-2

SEC FORM 4

$7,995,478.92

Adaptive Biotechnologies Corp (ADPT)

Sale of 318,799 shares at $25.08 per share.

Reporting Person ROBINS CHAD M · Officer Title CEO and Chairman · Transaction Code S

Traded Aug 17, 2026 · Disclosed Aug 19, 2026

Source: SEC Form 4 · 0001780649-26-000014 · filed 2026-08-19 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Adaptive Biotechnologies Corp (ADPT)." Disclosed 2026-08-19. https://desqlong.com/cards/0001780649-26-000014-2 (retrieved 2026-09-26).